Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Horning Sandra, Director. Officer active across 4 companies, notably EQRx, Inc.. Aggregated, 12 disclosures have been published. Activity tracked since 28 April 2022. The latest transaction was disclosed on 26 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations
Horning Sandra is Administrateur and has 12 filings in total. In the recent sample of 12 filings, the most common transaction nature is Attribution, with buy and sell amounts shown as EUR 0. The filings covered run from 2021-12-21 to 2025-06-30 and concern Revolution Medicines, Inc., Gilead Sciences, INC., Moderna, Inc. and EQRx, Inc.